Pseudomonas aeruginosa (CIP 102967, ATCC 29260, CCUG 31589)
BacDive ID
137804
Type strain
Strain Designation
PA-103
NCBI tax ID(s)
287
History
CIP <- 1987, ATCC <- P.V. Liu: strain PA-103 <- Louisville Gen. Hosp. USA
Links
Pseudomonas aeruginosa PA-103 is an aerobe, Gram-negative, motile bacterium of the family Pseudomonadaceae.
Gram-negative motile rod-shaped aerobe BacteriaName and taxonomic classification
| @ref 20215 |
|
Last LPSN update
2026-05-29 08:39:07 |
| Domain Bacteria |
| Phylum Pseudomonadota |
| Class Gammaproteobacteria |
| Order Pseudomonadales |
| Family Pseudomonadaceae |
| Genus Pseudomonas |
| Species Pseudomonas aeruginosa |
| Full scientific name Pseudomonas aeruginosa (Schroeter 1872) Migula 1900 (Approved Lists 1980) |
| Synonyms (2) |
Physiology and metabolism
Metabolite utilization
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 68369 | 17128 ChEBI | adipate | + | assimilation | from API 20NE |
| 68369 | 29016 ChEBI | arginine | + | hydrolysis | from API 20NE |
| 68369 | 17634 ChEBI | D-glucose | + | assimilation | from API 20NE |
| 68369 | 17634 ChEBI | D-glucose | - | fermentation | from API 20NE |
| 68369 | 16899 ChEBI | D-mannitol | + | assimilation | from API 20NE |
| 68369 | 16024 ChEBI | D-mannose | - | assimilation | from API 20NE |
| 68369 | 27689 ChEBI | decanoate | + | assimilation | from API 20NE |
| 68369 | 4853 ChEBI | esculin | + | hydrolysis | from API 20NE |
| 68369 | 5291 ChEBI | gelatin | - | hydrolysis | from API 20NE |
| 68369 | 24265 ChEBI | gluconate | + | assimilation | from API 20NE |
| 68369 | 30849 ChEBI | L-arabinose | - | assimilation | from API 20NE |
| 68369 | 25115 ChEBI | malate | + | assimilation | from API 20NE |
| 68369 | 17306 ChEBI | maltose | - | assimilation | from API 20NE |
| 68369 | 59640 ChEBI | N-acetylglucosamine | + | assimilation | from API 20NE |
| 38746 | 17632 ChEBI | nitrate | + | reduction | |
| 68369 | 17632 ChEBI | nitrate | + | reduction | from API 20NE |
| 38746 | 16301 ChEBI | nitrite | + | reduction | |
| 68369 | 27897 ChEBI | tryptophan | - | energy source | from API 20NE |
| 68369 | 16199 ChEBI | urea | - | hydrolysis | from API 20NE |
Metabolite production
Enzymes
| @ref | Value | Activity | Ec | |
|---|---|---|---|---|
| 68382 | acid phosphatase | + | 3.1.3.2 | from API zym |
| 68382 | alkaline phosphatase | + | 3.1.3.1 | from API zym |
| 68382 | alpha-chymotrypsin | - | 3.4.21.1 | from API zym |
| 68382 | alpha-fucosidase | - | 3.2.1.51 | from API zym |
| 68382 | alpha-galactosidase | - | 3.2.1.22 | from API zym |
| 68382 | alpha-glucosidase | - | 3.2.1.20 | from API zym |
| 68382 | alpha-mannosidase | - | 3.2.1.24 | from API zym |
| 68369 | arginine dihydrolase | + | 3.5.3.6 | from API 20NE |
| 68382 | beta-galactosidase | - | 3.2.1.23 | from API zym |
| 68382 | beta-glucosidase | - | 3.2.1.21 | from API zym |
| 68369 | beta-glucosidase | + | 3.2.1.21 | from API 20NE |
| 68382 | beta-glucuronidase | - | 3.2.1.31 | from API zym |
| 38746 | catalase | + | 1.11.1.6 | |
| 68382 | cystine arylamidase | - | 3.4.11.3 | from API zym |
| 68369 | cytochrome oxidase | + | 1.9.3.1 | from API 20NE |
| 68382 | esterase (C 4) | + | from API zym | |
| 68382 | esterase lipase (C 8) | + | from API zym | |
| 68369 | gelatinase | - | from API 20NE | |
| 68382 | leucine arylamidase | + | 3.4.11.1 | from API zym |
| 68382 | lipase (C 14) | - | from API zym | |
| 68382 | N-acetyl-beta-glucosaminidase | - | 3.2.1.52 | from API zym |
| 68382 | naphthol-AS-BI-phosphohydrolase | + | from API zym | |
| 38746 | oxidase | + | ||
| 68382 | trypsin | + | 3.4.21.4 | from API zym |
| 38746 | urease | + | 3.5.1.5 | |
| 68369 | urease | - | 3.5.1.5 | from API 20NE |
| 68382 | valine arylamidase | - | from API zym |
API zym
Literature
Literature 
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Immunomodulation by extracorporeal ozone-based bactericide system in porcine Pseudomonas aeruginosa septic shock. | Rundgren H, Sjoholm J, Juric S, Janson P, Kolerud J, Wallin R, Skorup P, Lipcsey M, Gunther M. | Sci Rep | 10.1038/s41598-025-07408-5 | 2025 | | |
| Pathogenicity | Monoclonal antibodies derived from B cells in subjects with cystic fibrosis reduce Pseudomonas aeruginosa burden in mice. | Hale M, Takehara KK, Thouvenel CD, Moustafa DA, Repele A, Fontana MF, Netland J, McNamara S, Gibson RL, Goldberg JB, Rawlings DJ, Pepper M. | Elife | 10.7554/elife.98851 | 2025 | |
| Chimeric bacteriocin S5-PmnH engineered by domain swapping efficiently controls Pseudomonas aeruginosa infection in murine keratitis and lung models. | Paskevicius S, Dapkute V, Misiunas A, Balzaris M, Thommes P, Sattar A, Gleba Y, Razanskiene A. | Sci Rep | 10.1038/s41598-022-09865-8 | 2022 | | |
| Functionalization of Bacterial Cellulose with the Antimicrobial Peptide KR-12 via Chimerical Cellulose-Binding Peptides. | van Zyl EM, Coburn JM. | Int J Mol Sci | 10.3390/ijms25031462 | 2024 | | |
| Metabolism | The Pseudomonas aeruginosa protease LasB directly activates IL-1beta. | Sun J, LaRock DL, Skowronski EA, Kimmey JM, Olson J, Jiang Z, O'Donoghue AJ, Nizet V, LaRock CN. | EBioMedicine | 10.1016/j.ebiom.2020.102984 | 2020 | |
| Metabolism | Dual Inhibition of Klebsiella pneumoniae and Pseudomonas aeruginosa Iron Metabolism Using Gallium Porphyrin and Gallium Nitrate. | Choi SR, Britigan BE, Narayanasamy P. | ACS Infect Dis | 10.1021/acsinfecdis.9b00100 | 2019 | |
| Rational Design of a Chimeric Derivative of PcrV as a Subunit Vaccine Against Pseudomonas aeruginosa. | Wan C, Zhang J, Zhao L, Cheng X, Gao C, Wang Y, Xu W, Zou Q, Gu J. | Front Immunol | 10.3389/fimmu.2019.00781 | 2019 | | |
| Metabolism | Iron/Heme Metabolism-Targeted Gallium(III) Nanoparticles Are Active against Extracellular and Intracellular Pseudomonas aeruginosa and Acinetobacter baumannii. | Choi SR, Britigan BE, Narayanasamy P. | Antimicrob Agents Chemother | 10.1128/aac.02643-18 | 2019 | |
| Antibacterial Activities and Antibacterial Mechanism of Polygonum cuspidatum Extracts against Nosocomial Drug-Resistant Pathogens. | Su PW, Yang CH, Yang JF, Su PY, Chuang LY. | Molecules | 10.3390/molecules200611119 | 2015 | | |
| A facile approach for development of a vaccine made of bacterial double-layered membrane vesicles (DMVs). | Wang S, Gao J, Li M, Wang L, Wang Z. | Biomaterials | 10.1016/j.biomaterials.2018.09.042 | 2018 | | |
| Inhaled bacteriophage-loaded polymeric microparticles ameliorate acute lung infections. | Agarwal R, Johnson CT, Imhoff BR, Donlan RM, McCarty NA, Garcia AJ. | Nat Biomed Eng | 10.1038/s41551-018-0263-5 | 2018 | | |
| Pathogenicity | Understanding Pseudomonas aeruginosa-Host Interactions: The Ongoing Quest for an Efficacious Vaccine. | Sainz-Mejias M, Jurado-Martin I, McClean S. | Cells | 10.3390/cells9122617 | 2020 | |
| Synthesis and biological screening of new thiadiazolopyrimidine-based polycyclic compounds. | Alqahtani AM. | Sci Rep | 10.1038/s41598-021-95241-x | 2021 | | |
| Metabolism | Neutrophil-Mediated Delivery of Therapeutic Nanoparticles across Blood Vessel Barrier for Treatment of Inflammation and Infection. | Chu D, Gao J, Wang Z. | ACS Nano | 10.1021/acsnano.5b05583 | 2015 | |
| An engineered human antibody fab fragment specific for Pseudomonas aeruginosa PcrV antigen has potent antibacterial activity. | Baer M, Sawa T, Flynn P, Luehrsen K, Martinez D, Wiener-Kronish JP, Yarranton G, Bebbington C. | Infect Immun | 10.1128/iai.00815-08 | 2009 | | |
| Metabolism | Relating the physical properties of Pseudomonas aeruginosa lipopolysaccharides to virulence by atomic force microscopy. | Ivanov IE, Kintz EN, Porter LA, Goldberg JB, Burnham NA, Camesano TA. | J Bacteriol | 10.1128/jb.01308-10 | 2011 | |
| Pathogenicity | Antimicrobial Activities and Mechanisms of Magnesium Oxide Nanoparticles (nMgO) against Pathogenic Bacteria, Yeasts, and Biofilms. | Nguyen NT, Grelling N, Wetteland CL, Rosario R, Liu H. | Sci Rep | 10.1038/s41598-018-34567-5 | 2018 | |
| Enzymology | Detection of Pseudomonas aeruginosa from clinical and environmental samples by amplification of the exotoxin A gene using PCR. | Khan AA, Cerniglia CE. | Appl Environ Microbiol | 10.1128/aem.60.10.3739-3745.1994 | 1994 | |
| Pathogenicity | Pyocin inhibition of Neisseria gonorrhoeae: mechanism of action. | Morse SA, Jones BV, Lysko PG. | Antimicrob Agents Chemother | 10.1128/aac.18.3.416 | 1980 | |
| Pathogenicity | Interaction with lectins and differential wheat germ agglutinin binding of pyocin 103-sensitive and -resistant Neisseria gonorrhoeae. | Connelly MC, Stein DC, Young FE, Morse SA, Allen PZ. | J Bacteriol | 10.1128/jb.148.3.796-803.1981 | 1981 | |
| Enzymology | Determination of genome size of Pseudomonas aeruginosa by PFGE: analysis of restriction fragments. | Hector JS, Johnson AR | Nucleic Acids Res | 10.1093/nar/18.11.3171 | 1990 | |
How to cite
If you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive137804.20260601.11
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain dataIsabel Schober, Julia Koblitz, Joaquim Sardà Carbasse, Christian Ebeling, Marvin Leon Schmidt, Adam Podstawka, Rohit Gupta, Vinodh Ilangovan, Javad Chamanara, Jörg Overmann, Lorenz Christian Reimer
Nucleic Acids Research; database issue 2025.
License